P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P08684 |
CP3A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 |
CP3A4_HUMAN |
Atopic eczema [ICD-11: EA80] |
P08684 |
CP3A4_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10275 |
ANDR_HUMAN |
Alcoholic liver disease [ICD-11: DB94] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P10275 |
ANDR_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P10275 |
ANDR_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P10275 |
ANDR_HUMAN |
Hypo-osmolality/hyponatraemia [ICD-11: 5C72] |
P10275 |
ANDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P10275 |
ANDR_HUMAN |
Mammary tumour [ICD-11: 2C60-2C6Z] |
P10275 |
ANDR_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Testicular dysfunction [ICD-11: 5A81] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Alopecia [ICD-11: ED70] |
P10275 |
ANDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P10275 |
ANDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P10275 |
ANDR_HUMAN |
Contraceptive management [ICD-11: QA21] |
P10275 |
ANDR_HUMAN |
Heart failure [ICD-11: BD10-BD1Z] |
P10275 |
ANDR_HUMAN |
Muscle disorder [ICD-11: FB32-FB3Z] |
P10275 |
ANDR_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P10275 |
ANDR_HUMAN |
Cystic fibrosis [ICD-11: CA25] |
P10275 |
ANDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P10275 |
ANDR_HUMAN |
Cachexia [ICD-11: MG20] |
P10275 |
ANDR_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P10275 |
ANDR_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P10275 |
ANDR_HUMAN |
Oesophagitis [ICD-11: DA24] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10275 |
ANDR_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
P10275 |
ANDR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 |
ANDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P10275 |
ANDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P10275 |
ANDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O95398 |
RPGF3_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
P43220 |
GLP1R_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 |
GLP1R_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P43220 |
GLP1R_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 |
GLP1R_HUMAN |
Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 |
GLP1R_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P43220 |
GLP1R_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P43220 |
GLP1R_HUMAN |
Dyspepsia [ICD-11: MD92] |
P43220 |
GLP1R_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
P43220 |
GLP1R_HUMAN |
Intracranial injury [ICD-11: NA07] |
P43220 |
GLP1R_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q03431 |
PTH1R_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q03431 |
PTH1R_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P19838 |
NFKB1_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P19838 |
NFKB1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P19838 |
NFKB1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P11511 |
CP19A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P11511 |
CP19A_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P11511 |
CP19A_HUMAN |
Oesophagitis [ICD-11: DA24] |
P11511 |
CP19A_HUMAN |
Endometriosis [ICD-11: GA10] |
P11511 |
CP19A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P11511 |
CP19A_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P11511 |
CP19A_HUMAN |
Prostate disease [ICD-11: GA91] |
Q13148 |
TADBP_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 |
TADBP_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P03372 |
ESR1_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P03372 |
ESR1_HUMAN |
Acquired prion disease [ICD-11: 8E01] |
P03372 |
ESR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P03372 |
ESR1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P03372 |
ESR1_HUMAN |
Contraceptive management [ICD-11: QA21] |
P03372 |
ESR1_HUMAN |
Dyspareunia [ICD-11: GA12] |
P03372 |
ESR1_HUMAN |
Female infertility [ICD-11: GA31] |
P03372 |
ESR1_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P03372 |
ESR1_HUMAN |
Male infertility [ICD-11: GB04] |
P03372 |
ESR1_HUMAN |
Menopausal disorder [ICD-11: GA30] |
P03372 |
ESR1_HUMAN |
Menstrual cycle bleeding disorder [ICD-11: GA20] |
P03372 |
ESR1_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P03372 |
ESR1_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P03372 |
ESR1_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
P03372 |
ESR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P03372 |
ESR1_HUMAN |
Vaginitis [ICD-11: GA02] |
P03372 |
ESR1_HUMAN |
Virus infection [ICD-11: 1A24-1D9Z] |
P03372 |
ESR1_HUMAN |
Endometriosis [ICD-11: GA10] |
P03372 |
ESR1_HUMAN |
Female genital tract noninflammatory disorder [ICD-11: GA1Y] |
P03372 |
ESR1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P03372 |
ESR1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P03372 |
ESR1_HUMAN |
Breast in situ carcinoma [ICD-11: 2E65] |
P03372 |
ESR1_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P03372 |
ESR1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P03372 |
ESR1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P03372 |
ESR1_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
P03372 |
ESR1_HUMAN |
Irregularities [ICD-11: N.A.] |
P03372 |
ESR1_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
P03372 |
ESR1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P03372 |
ESR1_HUMAN |
Eye disorder [ICD-11: 9A01-9A0Z] |
P03372 |
ESR1_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P03372 |
ESR1_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P03372 |
ESR1_HUMAN |
Atrophy [ICD-11: 9A2Y-9C40] |
P03372 |
ESR1_HUMAN |
Joint pain [ICD-11: ME82] |
P03372 |
ESR1_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
P03372 |
ESR1_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P03372 |
ESR1_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P03372 |
ESR1_HUMAN |
Acquired prion disease [ICD-11: 8E01] |
P03372 |
ESR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P03372 |
ESR1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P03372 |
ESR1_HUMAN |
Contraceptive management [ICD-11: QA21] |
P03372 |
ESR1_HUMAN |
Dyspareunia [ICD-11: GA12] |
P03372 |
ESR1_HUMAN |
Female infertility [ICD-11: GA31] |
P03372 |
ESR1_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P03372 |
ESR1_HUMAN |
Male infertility [ICD-11: GB04] |
P03372 |
ESR1_HUMAN |
Menopausal disorder [ICD-11: GA30] |
P03372 |
ESR1_HUMAN |
Menstrual cycle bleeding disorder [ICD-11: GA20] |
P03372 |
ESR1_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P03372 |
ESR1_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P03372 |
ESR1_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
P03372 |
ESR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P03372 |
ESR1_HUMAN |
Vaginitis [ICD-11: GA02] |
P03372 |
ESR1_HUMAN |
Virus infection [ICD-11: 1A24-1D9Z] |
P03372 |
ESR1_HUMAN |
Endometriosis [ICD-11: GA10] |
P03372 |
ESR1_HUMAN |
Female genital tract noninflammatory disorder [ICD-11: GA1Y] |
P03372 |
ESR1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P03372 |
ESR1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P03372 |
ESR1_HUMAN |
Breast in situ carcinoma [ICD-11: 2E65] |
P03372 |
ESR1_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P03372 |
ESR1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P03372 |
ESR1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P03372 |
ESR1_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
P03372 |
ESR1_HUMAN |
Irregularities [ICD-11: N.A.] |
P03372 |
ESR1_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
P03372 |
ESR1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P03372 |
ESR1_HUMAN |
Eye disorder [ICD-11: 9A01-9A0Z] |
P03372 |
ESR1_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P03372 |
ESR1_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P03372 |
ESR1_HUMAN |
Atrophy [ICD-11: 9A2Y-9C40] |
P03372 |
ESR1_HUMAN |
Joint pain [ICD-11: ME82] |
P03372 |
ESR1_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
P03372 |
ESR1_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P03372 |
ESR1_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P03372 |
ESR1_HUMAN |
Acquired prion disease [ICD-11: 8E01] |
P03372 |
ESR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P03372 |
ESR1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P03372 |
ESR1_HUMAN |
Contraceptive management [ICD-11: QA21] |
P03372 |
ESR1_HUMAN |
Dyspareunia [ICD-11: GA12] |
P03372 |
ESR1_HUMAN |
Female infertility [ICD-11: GA31] |
P03372 |
ESR1_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P03372 |
ESR1_HUMAN |
Male infertility [ICD-11: GB04] |
P03372 |
ESR1_HUMAN |
Menopausal disorder [ICD-11: GA30] |
P03372 |
ESR1_HUMAN |
Menstrual cycle bleeding disorder [ICD-11: GA20] |
P03372 |
ESR1_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P03372 |
ESR1_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P03372 |
ESR1_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
P03372 |
ESR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P03372 |
ESR1_HUMAN |
Vaginitis [ICD-11: GA02] |
P03372 |
ESR1_HUMAN |
Virus infection [ICD-11: 1A24-1D9Z] |
P03372 |
ESR1_HUMAN |
Endometriosis [ICD-11: GA10] |
P03372 |
ESR1_HUMAN |
Female genital tract noninflammatory disorder [ICD-11: GA1Y] |
P03372 |
ESR1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P03372 |
ESR1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P03372 |
ESR1_HUMAN |
Breast in situ carcinoma [ICD-11: 2E65] |
P03372 |
ESR1_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P03372 |
ESR1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P03372 |
ESR1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P03372 |
ESR1_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
P03372 |
ESR1_HUMAN |
Irregularities [ICD-11: N.A.] |
P03372 |
ESR1_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
P03372 |
ESR1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P03372 |
ESR1_HUMAN |
Eye disorder [ICD-11: 9A01-9A0Z] |
P03372 |
ESR1_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P03372 |
ESR1_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P03372 |
ESR1_HUMAN |
Atrophy [ICD-11: 9A2Y-9C40] |
P03372 |
ESR1_HUMAN |
Joint pain [ICD-11: ME82] |
P03372 |
ESR1_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
P03372 |
ESR1_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P03372 |
ESR1_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P03372 |
ESR1_HUMAN |
Acquired prion disease [ICD-11: 8E01] |
P03372 |
ESR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P03372 |
ESR1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P03372 |
ESR1_HUMAN |
Contraceptive management [ICD-11: QA21] |
P03372 |
ESR1_HUMAN |
Dyspareunia [ICD-11: GA12] |
P03372 |
ESR1_HUMAN |
Female infertility [ICD-11: GA31] |
P03372 |
ESR1_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P03372 |
ESR1_HUMAN |
Male infertility [ICD-11: GB04] |
P03372 |
ESR1_HUMAN |
Menopausal disorder [ICD-11: GA30] |
P03372 |
ESR1_HUMAN |
Menstrual cycle bleeding disorder [ICD-11: GA20] |
P03372 |
ESR1_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P03372 |
ESR1_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P03372 |
ESR1_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
P03372 |
ESR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P03372 |
ESR1_HUMAN |
Vaginitis [ICD-11: GA02] |
P03372 |
ESR1_HUMAN |
Virus infection [ICD-11: 1A24-1D9Z] |
P03372 |
ESR1_HUMAN |
Endometriosis [ICD-11: GA10] |
P03372 |
ESR1_HUMAN |
Female genital tract noninflammatory disorder [ICD-11: GA1Y] |
P03372 |
ESR1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P03372 |
ESR1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P03372 |
ESR1_HUMAN |
Breast in situ carcinoma [ICD-11: 2E65] |
P03372 |
ESR1_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P03372 |
ESR1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P03372 |
ESR1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P03372 |
ESR1_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
P03372 |
ESR1_HUMAN |
Irregularities [ICD-11: N.A.] |
P03372 |
ESR1_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
P03372 |
ESR1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P03372 |
ESR1_HUMAN |
Eye disorder [ICD-11: 9A01-9A0Z] |
P03372 |
ESR1_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P03372 |
ESR1_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P03372 |
ESR1_HUMAN |
Atrophy [ICD-11: 9A2Y-9C40] |
P03372 |
ESR1_HUMAN |
Joint pain [ICD-11: ME82] |
P03372 |
ESR1_HUMAN |
Sexual dysfunction [ICD-11: HA00-HA01] |
P03372 |
ESR1_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P31645 |
SC6A4_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P31645 |
SC6A4_HUMAN |
Attention deficit hyperactivity disorder [ICD-11: 6A05] |
P31645 |
SC6A4_HUMAN |
Binge eating disorder [ICD-11: 6B82] |
P31645 |
SC6A4_HUMAN |
Chronic pain [ICD-11: MG30] |
P31645 |
SC6A4_HUMAN |
concerning food/fluid intake symptom [ICD-11: MG43] |
P31645 |
SC6A4_HUMAN |
Corneal disease [ICD-11: 9A76-9A78] |
P31645 |
SC6A4_HUMAN |
Cough [ICD-11: MD12] |
P31645 |
SC6A4_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P31645 |
SC6A4_HUMAN |
Menopausal disorder [ICD-11: GA30] |
P31645 |
SC6A4_HUMAN |
Migraine [ICD-11: 8A80] |
P31645 |
SC6A4_HUMAN |
Mood disorder [ICD-11: 6A60-6E23] |
P31645 |
SC6A4_HUMAN |
Nicotine use disorder [ICD-11: 6C4A] |
P31645 |
SC6A4_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P31645 |
SC6A4_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P31645 |
SC6A4_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P31645 |
SC6A4_HUMAN |
General pain disorder [ICD-11: 8E43] |
P31645 |
SC6A4_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
P31645 |
SC6A4_HUMAN |
Neurobehavioral disorder [ICD-11: 8A00-8A0Z] |
P31645 |
SC6A4_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P31645 |
SC6A4_HUMAN |
Substance abuse [ICD-11: 6C40] |
P31645 |
SC6A4_HUMAN |
Cocaine use disorder [ICD-11: 6C45] |
P31645 |
SC6A4_HUMAN |
Ejaculatory dysfunction [ICD-11: HA03] |
P31645 |
SC6A4_HUMAN |
Orthostatic hypotension [ICD-11: BA21] |
P31645 |
SC6A4_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P31645 |
SC6A4_HUMAN |
Nausea/vomiting [ICD-11: MD90] |
P31645 |
SC6A4_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P31645 |
SC6A4_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P31645 |
SC6A4_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P31645 |
SC6A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P41595 |
5HT2B_HUMAN |
Depression [ICD-11: 6A70-6A7Z] |
P41595 |
5HT2B_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P41595 |
5HT2B_HUMAN |
Psychotic disorder [ICD-11: 6A20-6A25] |
P41595 |
5HT2B_HUMAN |
Attention deficit hyperactivity disorder [ICD-11: 6A05] |
P41595 |
5HT2B_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
P41595 |
5HT2B_HUMAN |
Coronary atherosclerosis [ICD-11: BA80] |
P41595 |
5HT2B_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
P41595 |
5HT2B_HUMAN |
Migraine [ICD-11: 8A80] |
P41595 |
5HT2B_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q92731 |
ESR2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q92731 |
ESR2_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
Q92731 |
ESR2_HUMAN |
Menopausal disorder [ICD-11: GA30] |
Q92731 |
ESR2_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
Q92731 |
ESR2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
Q92731 |
ESR2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q92731 |
ESR2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
Q92731 |
ESR2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q92731 |
ESR2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
Q92731 |
ESR2_HUMAN |
Prostate hyperplasia [ICD-11: GA90] |
Q92731 |
ESR2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
Q92731 |
ESR2_HUMAN |
Irregularities [ICD-11: N.A.] |
Q92731 |
ESR2_HUMAN |
Trematode disease [ICD-11: 1F8Y] |
Q92731 |
ESR2_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q92731 |
ESR2_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
Q92731 |
ESR2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q92731 |
ESR2_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
Q92731 |
ESR2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q16665 |
HIF1A_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q16665 |
HIF1A_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q16665 |
HIF1A_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
Q16665 |
HIF1A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16665 |
HIF1A_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
P22309 |
UD11_HUMAN |
Inborn porphyrin/heme metabolism error [ICD-11: 5C58] |
P15289 |
ARSA_HUMAN |
Lysosomal disease [ICD-11: 5C56] |
P08185 |
CBG_HUMAN |
Asthma [ICD-11: CA23] |
P08185 |
CBG_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P08185 |
CBG_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P08185 |
CBG_HUMAN |
Retinopathy [ICD-11: 9B71] |
Q9UNQ0 |
ABCG2_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
Q9UNQ0 |
ABCG2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
Q96T53 |
MBOA4_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
Q96T53 |
MBOA4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P08842 |
STS_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P08842 |
STS_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P08842 |
STS_HUMAN |
Endometriosis [ICD-11: GA10] |
P08842 |
STS_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P08842 |
STS_HUMAN |
Prostate cancer [ICD-11: 2C82] |